In light of the holiday season, LAC (pronounced as L-A-C), is dedicated to maintaining optimal stress and immunity levels ...

Knight found that in nations with high pet ownership - such as the US, pet food consumes around 20% of all land animals ...

As the flagship toy fair in Asia and the HKTDC’s first trade show of the year, the Hong Kong Toys & Games Fair, along with ...

香港, 2025年1月2日 - (亞太商訊) - ...

Richard Tsang, Founder and Chairman of SPRG, said, “The chewy bubbles represent pearls, which fit perfectly with our 30th ...

香港, 2025年1月2日 - (亚太商讯) - 纵横公共关系顾问集团 (简称「纵横公关集团」或「集团」) ...

縱橫公關集團於1995年在香港成立之時以投資者關係服務為核心，至今已發展成為輻射亞太區、服務本地及國際客戶的綜合公關顧問。集團在亞太區8大據點聘有超過250名公關專才，同時透過分佈世界各地的夥伴和PROI ...

SHANGHAI, China - January 2, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufact ...

耐賦康 (R)於2024年11月被納入國家醫保藥品目錄。作為全球首個獲得美國食品藥品監督管理局（FDA）和歐洲藥品管理局（EMA）完全批准的IgA腎病治療藥物，耐賦康 (R)於2023年11月通過優先審評程式正式獲得中國國家藥品監督管理局的批准，用於治療具有進展風險的原發性IgA腎病成人患者，是中國唯一獲得IgA腎病適應症的治療藥物。

耐赋康 (R)于2024年11月被纳入国家医保药品目录。作为全球首个获得美国食品药品监督管理局（FDA）和欧洲药品管理局（EMA）完全批准的IgA肾病治疗药物，耐赋康 (R)于2023年11月通过优先审评程序正式获得中国国家药品监督管理局的批准，用于治疗具有进展风险的原发性IgA肾病成人患者，是中国唯一获得IgA肾病适应症的治疗药物。

Ms. Amy Leong, Chief Executive Officer of AEM, commented, “We are pleased to have Mr. Kwek join the team, and believe his experience and knowledge will be an invaluable asset to the team in helping us ...

Winning the award for Excellence in Financial Services for our platform innovation, is an important achievement for Capital Revo. It highlights the firm's industry-leading position in finance, as well ...